Circadin 2mg prolonged-release tablets

Product Information *

  • Company:

    Flynn Pharma Ltd
  • Status:

    No Recent Update
  • Active Ingredients :

    *Additional information is available upon request

  • Legal Category:

    Product subject to medical prescription which may be renewed (B)

When a pharmaceutical company changes any document, a new version is published on medicines.ie. For each version, we show the dates it was published on medicines.ie and the reasons for change.

Updated on 19 January 2021

File name

Circadin PIL 2020 text_1611073482.pdf

Reasons for updating

  • New PIL for new product

Updated on 04 June 2020

File name

Circadin SmPC_1591287115.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

updates to section 4.2 and 5.1

Updated on 04 June 2020

File name

Circadin SmPC_1591287049.pdf

Reasons for updating

  • Change to section 4.2 - Posology and method of administration
  • Change to section 5.1 - Pharmacodynamic properties

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 28 August 2019

File name

circadin-smpc_1566978758.pdf

Reasons for updating

  • File format updated to PDF

Legal category:Product subject to medical prescription which may be renewed (B)

Updated on 07 June 2018

File name

Circadin SmPC 30.05.18.docx

Reasons for updating

  • Change to section 7 - Marketing authorisation holder

Legal category:Product subject to medical prescription which may be renewed (B)

Free text change information supplied by the pharmaceutical company

Update in the MA holder address

Updated on 09 August 2016

Reasons for updating

  • New SPC for new product

Legal category:Product subject to medical prescription which may be renewed (B)